Cas9 Stable Cell Line - A-427

The A-427-Cas9 stable cell line is a robust genetic model for lung cancer, constructed by integrating the Cas9 nuclease into the human A-427 cell line. A-427 is an adherent epithelial cell line isolated from a lung cancer patient definitively diagnosed with adenocarcinoma. These cells are characterized by stable growth and sensitivity to various viral vectors. Constitutive expression of Cas9 in this cell line ensures that gene editing mechanisms are consistently optimized, providing an efficient and reproducible system for CRISPR-mediated genome editing. By constructing a stable cell line, researchers can avoid the instability and toxicity associated with transient transfection, making it a reliable platform for functional genomics and cellular signaling pathway exploration in human lung cancer research.

The primary applications of the A-427-Cas9 stable cell line are in studying the pathogenesis of lung adenocarcinoma and screening for novel therapeutic targets. Researchers utilize this system for large-scale CRISPR screening to identify genes involved in tumor cell proliferation, survival, and resistance mechanisms to targeted therapy and chemotherapy drugs. The A-427-Cas9 cell line is particularly well-suited for constructing homologous clones with specific gene knockouts, enabling scientists to study the roles of lung-specific oncogenes and tumor suppressor genes in disease progression. Furthermore, it serves as a reliable platform for evaluating the efficacy of novel anticancer compounds and investigating the molecular pathways of lung epithelial cells in response to environmental toxins and inflammatory stimuli. Its well-defined adenocarcinoma background and stable Cas9 expression make it an indispensable resource for advancing personalized treatment strategies for lung cancer.